South Korea Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2024-2032

South Korea Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A20329
Buy Now

Market Overview:

South Korea biomarkers market size is projected to exhibit a growth rate (CAGR) of 13.86% during ​2024-2032​. The growing integration of omics technologies, such as genomics, proteomics, and metabolomics, rising integration of artificial intelligence (AI) and machine learning (ML), and increasing investments in research and development (R&D) represent some of the key factors driving the market.

Report Attribute
 Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Growth Rate (2024-2032) 13.86%


Biomarkers encompass a broad range of substances or characteristics that can be objectively evaluated. They comprise diagnostic biomarkers like specific proteins or genetic markers associated with a particular disease, which identify the presence of an ailment or condition. They also consist of prognostic biomarkers, which predict the likely course and outcome of a disease. They include deoxyribonucleic acid (DNA), ribonucleic acid (RNA), proteins, and metabolites, providing information about genetic variations, gene expression, and metabolic processes. They help in visualizing physiological and anatomical changes associated with diseases by using advanced imaging techniques, such as magnetic resonance imaging (MRI) and positron emission tomography (PET) scans. They play essential parts in cellular functions, and alterations in their levels or structure can indicate disease states. Biomarkers facilitate the early detection of diseases, enabling intervention at a stage when treatment is more effective. They play a pivotal role in personalized medicine by allowing healthcare professionals to tailor treatments as per individual requirements. They are integral in drug development, aiding in the identification of potential drug targets, evaluating treatment efficacy, and predicting adverse effects. They contribute to a deeper understanding of disease mechanisms, fostering advancements in basic and translational research. They drive breakthroughs in understanding disease biology, paving the way for innovative therapies and diagnostic tools.

South Korea Biomarkers Market Trends:

At present, the increasing integration of omics technologies, such as genomics, proteomics, and metabolomics, represents one of the crucial factors impelling the market growth in South Korea. Advances in these fields are facilitating the identification of a myriad of biomolecules that can serve as precise and specific markers for various diseases. The ability to analyze the molecular profile of an individual allows for more accurate and targeted diagnosis is facilitating the development of personalized medicine strategies in the country. Besides this, the rising prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurodegenerative disorders, is contributing to the market growth. Biomarkers play a pivotal part in the early detection and monitoring of these conditions, contributing to timely interventions and improved patient outcomes. In addition, the growing integration of artificial intelligence (AI) and machine learning (ML) into biomarker discovery and analysis is offering a favorable market outlook. Apart from this, precision medicine focuses on tailoring medical treatment processes to the individual characteristics of each patient, considering their genetic makeup, lifestyle, and environmental factors. Biomarkers are integral to this approach, as they enable the examination of patients who are likely to respond positively to specific treatments. Additionally, the rising demand for non-invasive biomarkers, driven by the desire to enhance patient compliance, reduce healthcare costs, and improve the overall diagnostic experience, is bolstering the market growth.

South Korea Biomarkers Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for ​2024-2032​. Our report has categorized the market based on product, type, disease, application, and end user.

Product Insights:

  • Consumables
  • Services
  • Software
     

The report has provided a detailed breakup and analysis of the market based on the product. This includes consumables, services, and software.

Type Insights:

  • Efficacy Biomarkers
  • Safety Biomarkers
  • Validation Biomarkers
     

A detailed breakup and analysis of the market based on the type have also been provided in the report. This includes efficacy biomarkers, safety biomarkers, and validation biomarkers.

Disease Insights:

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Immunological Disorders
  • Renal Disorders
  • Others
     

The report has provided a detailed breakup and analysis of the market based on the disease. This includes cancer, cardiovascular disorders, neurological disorders, immunological disorders, renal disorders, and others.

Application Insights:

  • Diagnostics
  • Drug Discovery and Development
  • Personalized Medicine
  • Others
     

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes diagnostics, drug discovery and development, personalized medicine, and others.

End User Insights:

  • Pharmaceutical and Biotechnology Companies
  • Diagnostic and Research Laboratories
  • Hospitals and Specialty Clinics
  • Others
     

The report has provided a detailed breakup and analysis of the market based on the end user. This includes pharmaceutical and biotechnology companies, diagnostic and research laboratories, hospitals and specialty clinics, and others.

Regional Insights:

  • Seoul Capital Area
  • Yeongnam (Southeastern Region)
  • Honam (Southwestern Region)
  • Hoseo (Central Region)
  • Others
     

The report has also provided a comprehensive analysis of all the major regional markets, which include Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region) and Others.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

South Korea Biomarkers Market Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: 
  • Product
  • Type
  • Disease
  • Application
  • End User
  • Region
Products Covered Consumables, Services, Software
Types Covered Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers
Diseases Covered Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, Others
Applications Covered Diagnostics, Drug Discovery and Development, Personalized Medicine, Others
End Users Covered Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, Others
Regions Covered Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), Others
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the South Korea biomarkers market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the South Korea biomarkers market?
  • What is the breakup of the South Korea biomarkers market on the basis of product?
  • What is the breakup of the South Korea biomarkers market on the basis of type?
  • What is the breakup of the South Korea biomarkers market on the basis of disease?
  • What is the breakup of the South Korea biomarkers market on the basis of application?
  • What is the breakup of the South Korea biomarkers market on the basis of end user?
  • What are the various stages in the value chain of the South Korea biomarkers market? 
  • What are the key driving factors and challenges in the South Korea biomarkers?
  • What is the structure of the South Korea biomarkers market and who are the key players?
  • What is the degree of competition in the South Korea biomarkers market?

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the South Korea biomarkers market from 2018-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the South Korea biomarkers market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the South Korea biomarkers industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
South Korea Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More